"However, the mechanism underlying DOK1 silencing remains largely unknown. We show here that unscheduled silencing of DOK1 expression through aberrant hypermethylation is a frequent event in a variety of human malignancies. DOK1 was found to be silenced in nine head and neck cancer (HNC) cell lines studied and DOK1 CpG hypermethylation...
In order to view the entire article, please read your options to the right
If you have an account with NewsRx and have purchased either a NewsRx Bundled package or a NewsRx Pass, you can log into your account below to access this article.
If you are new to NewsRx, you may also take advantage of cost-saving options such as those below to view this article.
View an unlimited number of articles for a day, week, month, etc.
Purchase a bundle of article-viewing-credits that never expire and receive a discount of up to 50%!
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.